TY - JOUR
T1 - Trypanosoma brucei interaction with host: Mechanism of VSG release as target for drug discovery for african trypanosomiasis
AU - Moreno, Cláudia Jassica Gonçalves
AU - Temporão, Adriana
AU - Torres, Taffarel
AU - Silva, Marcelo Sousa
N1 - This research was funded by GHTM-UID/multi/04413/2013 (FCT-Portugal) and Grant number 019/2013 (Capes-Brazil).
PY - 2019/3/2
Y1 - 2019/3/2
N2 - The protozoan Trypanosoma brucei, responsible for animal and human trypanosomiasis, has a family of major surface proteases (MSPs) and phospholipase-C (PLC), both involved in some mechanisms of virulence during mammalian infections. During parasitism in the mammalian host, this protozoan is exclusively extracellular and presents a robust mechanism of antigenic variation that allows the persistence of infection. There has been incredible progress in our understanding of how variable surface glycoproteins (VSGs) are organised and expressed, and how expression is switched, particularly through recombination. The objective of this manuscript is to create a reflection about the mechanisms of antigenic variation in T. brucei, more specifically, in the process of variable surface glycoprotein (VSG) release. We firstly explore the mechanism of VSG release as a potential pathway and target for the development of anti-T. brucei drugs.
AB - The protozoan Trypanosoma brucei, responsible for animal and human trypanosomiasis, has a family of major surface proteases (MSPs) and phospholipase-C (PLC), both involved in some mechanisms of virulence during mammalian infections. During parasitism in the mammalian host, this protozoan is exclusively extracellular and presents a robust mechanism of antigenic variation that allows the persistence of infection. There has been incredible progress in our understanding of how variable surface glycoproteins (VSGs) are organised and expressed, and how expression is switched, particularly through recombination. The objective of this manuscript is to create a reflection about the mechanisms of antigenic variation in T. brucei, more specifically, in the process of variable surface glycoprotein (VSG) release. We firstly explore the mechanism of VSG release as a potential pathway and target for the development of anti-T. brucei drugs.
KW - Antigenic variation
KW - Major surface protease
KW - Phospholipase-C
KW - Trypanosoma brucei
KW - Variable surface glycoprotein
UR - http://www.scopus.com/inward/record.url?scp=85064208217&partnerID=8YFLogxK
U2 - 10.3390/ijms20061484
DO - 10.3390/ijms20061484
M3 - Review article
C2 - 30934540
AN - SCOPUS:85064208217
SN - 1661-6596
VL - 20
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
IS - 6
M1 - 1484
ER -